Cargando…
Safety and Efficacy of Methoxy Polyethylene Glycol-epoetin Beta in Anemia Treatment in Patients on Hemodialysis: a Macedonian Experience
INTRODUCTION: Anemia in patients with chronic kidney disease (CKD) is present in about 50% in pre-dialysis and over 90% of patients on hemodialysis. Erythropoiesis-stimulating agent (ESA) is a standard therapy for renal anemia, but management of anemia in CKD still remains a challenge from the treat...
Autores principales: | Kacarska - Fotevska, Isidora Isidora, Volckova, Nadja, Ilievska, Katerina, Donev, Doncho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Medical Sciences of Bosnia and Herzegovina
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296413/ https://www.ncbi.nlm.nih.gov/pubmed/32577051 http://dx.doi.org/10.5455/medarh.2020.74.109-114 |
Ejemplares similares
-
Toward confirmation of the safety and efficacy of methoxy polyethylene glycol-epoetin beta in anemia treatment in patients on hemodialysis: a Macedonian experience
por: Kacarska-Fotevska, Isidora, et al.
Publicado: (2019) -
Methoxy polyethylene glycol-epoetin beta for anemia with chronic kidney disease
por: Ohashi, Naro, et al.
Publicado: (2012) -
The resistance to methoxy polyethylene glycol-epoetin beta in anemic patients of end-stage renal disease
por: Abood, Sattar J., et al.
Publicado: (2023) -
Macedonian Association of Medical Editors Initiatives to Advance the Integrity of Science and Publishing
por: Donev, Doncho
Publicado: (2021) -
Macedonian Medical Association – Seventy Years from Its Establishment, 1945-2015
por: Donev, Doncho
Publicado: (2016)